Cite
Regional analysis of a cohort compassionate-use program (CUP) and early access program (EAP) with cabazitaxel (Cbz) plus prednisone (P; Cbz + P) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel (D)
MLA
Geoffrey Matus, et al. “Regional Analysis of a Cohort Compassionate-Use Program (CUP) and Early Access Program (EAP) with Cabazitaxel (Cbz) plus Prednisone (P; Cbz + P) in Patients (Pts) with Metastatic Castration-Resistant Prostate Cancer (MCRPC) Previously Treated with Docetaxel (D).” Journal of Clinical Oncology, vol. 32, Feb. 2014, p. 242. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........aaba89fc4e22d59dd228c1f3c46ca61e&authtype=sso&custid=ns315887.
APA
Geoffrey Matus, Inge M. van Oort, Luis M. Antón Aparicio, Fred Saad, Phillip Parente, Sergio Bracarda, Axel Heidenreich, Mert Basaran, Alexandros Ardavanis, Winald R. Gerritsen, Wito de Schultz, Simon Hitier, Giuseppe Di Lorenzo, Amit Bahl, & Zafar Malik. (2014). Regional analysis of a cohort compassionate-use program (CUP) and early access program (EAP) with cabazitaxel (Cbz) plus prednisone (P; Cbz + P) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel (D). Journal of Clinical Oncology, 32, 242.
Chicago
Geoffrey Matus, Inge M. van Oort, Luis M. Antón Aparicio, Fred Saad, Phillip Parente, Sergio Bracarda, Axel Heidenreich, et al. 2014. “Regional Analysis of a Cohort Compassionate-Use Program (CUP) and Early Access Program (EAP) with Cabazitaxel (Cbz) plus Prednisone (P; Cbz + P) in Patients (Pts) with Metastatic Castration-Resistant Prostate Cancer (MCRPC) Previously Treated with Docetaxel (D).” Journal of Clinical Oncology 32 (February): 242. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........aaba89fc4e22d59dd228c1f3c46ca61e&authtype=sso&custid=ns315887.